FindTrial
Sign In

The effect of baclofen on food craving scores and binge eating episodes in obese subjects

The effect of baclofen on food craving scores and binge eating episodes in obese subjects - The baclofen study

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37514
Enrollment
40
Registered
2012-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity overweight

Interventions

Baclofen will be started with an initial doses of 5 mg a day. Every day 5 mg baclofen extra will be added tot the dosage with a final maximum dosage of 20 mg three times a day.

Sponsors

Slotervaartziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - BMI above 30 - Age 18 years or older - obtained informed consent - sufficient command of the dutch language

Exclusion criteria

Exclusion criteria: - Diagnosis of type 1 or type 2 diabetes - obesity induced by other endocrinologic disorders - current or history of treatment with medication that may cause significant weight gain, within 3 months prior to screening

Design outcomes

Primary

MeasureTime frame
Food-craving score, measured by the food craving questionnaire—

Secondary

MeasureTime frame
Binge eating Body weight—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)